None at this time

( DrugBank: - / KEGG DRUG: - )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
96	クローン病	1

告示番号	疾患名（ページ内リンク）	臨床試験数
140	ドラベ症候群	2

96. クローン病

臨床試験数 : 2,442 / 薬物数 : 1,278 - (DrugBank : 248) / 標的遺伝子数 : 142 - 標的パスウェイ数 : 209

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2019-000886-19-FR (EUCTR)	20/01/2020	26/07/2019	A study to evaluate the effects of TAK-018 on recurrence of Crohn’s Disease patients after bowel res ...	A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 2a Study to Evaluate the Safety, ...	Crohn’s Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Crohn's disease;Sy ...	Product Code: TAK-018 INN or Proposed INN: None at this time Other descriptive name: EB8018 Product Cod ...	Millennium Pharmaceuticals, Inc (a wholly owned subsidiary	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	75	Phase 2	United States;France;Germany;United Kingdom

臨床試験数 : 116 / 薬物数 : 65 - (DrugBank : 17) / 標的遺伝子数 : 50 - 標的パスウェイ数 : 64

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2018-002484-25-PT (EUCTR)	29/04/2019	19/11/2018	A phase 2, multicenter, randomized, double-blind, controlled with placebo, to obtaine efficacy , saf ...	A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY, ...	Epileptic Encephalitis: Dravet and Lennox Gastuat syndrome (LGS);Therapeutic area: Diseases [C] - Ne ...	Product Code: TAK-935 INN or Proposed INN: None at this time Product Code: TAK-935 INN or Proposed INN: ...	Takeda Development Center Americas, Inc.	NULL	Not Recruiting			Female: yes Male: yes	126	Phase 2	United States;Portugal;Canada;Spain;Poland;Australia;Israel;China
2	EUCTR2018-002484-25-PL (EUCTR)	14/03/2019	11/12/2018	A phase 2, multicenter, randomized, double-blind, controlled with placebo, to obtaine efficacy , saf ...	A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY, ...	Epileptic Encephalitis: Dravet and Lennox Gastuat syndrome (LGS);Therapeutic area: Diseases [C] - Ne ...	Product Code: TAK-935 INN or Proposed INN: None at this time Product Code: TAK-935 INN or Proposed INN: ...	Takeda Development Center Americas, Inc.	NULL	Not Recruiting			Female: yes Male: yes	126	Phase 2	United States;Portugal;Canada;Spain;Poland;Australia;Israel;China